Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model

Effects of Influenza Vaccination in the United States during the 2017–2018 Influenza Season

(2019) Melissa A Rolfes et al.   CLINICAL INFECTIOUS DISEASES

Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase

(2019) Felix Broecker et al.   JOURNAL OF VIROLOGY

Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus

(2019) Ki-Hye Kim et al.   VIROLOGY

Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018–2019 Season

(2019) Brendan Flannery et al.   JOURNAL OF INFECTIOUS DISEASES

Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies

(2018) Yao-Qing Chen et al.   CELL

Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza

(2018) Elizabeth Q. Littauer et al.   JOURNAL OF CONTROLLED RELEASE

Sialidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype

(2018) Lisa Walz et al.   JOURNAL OF VIROLOGY

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

(2018) A Danielle Iuliano et al.   LANCET

Influenza Vaccine Effectiveness in the United States during the 2016–2017 Season

(2018) Brendan Flannery et al.   CLINICAL INFECTIOUS DISEASES

Influenza virus-like particles composed of conserved influenza proteins and GPI-anchored CCL28/GM-CSF fusion proteins enhance protective immunity against homologous and heterologous viruses

(2018) Jing Liu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Molecular epidemiology of swine influenza A viruses in the Southeastern United States, highlights regional differences in circulating strains

(2017) Constantinos S. Kyriakis et al.   VETERINARY MICROBIOLOGY

Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets

(2017) Gale E. Smith et al.   VIROLOGY

Live baculovirus acts as a strong B and T cell adjuvant for monomeric and oligomeric protein antigens

(2017) Suvi Heinimäki et al.   VIROLOGY

H1N1 influenza virus infection results in adverse pregnancy outcomes by disrupting tissue-specific hormonal regulation

(2017) Elizabeth Q. Littauer et al.   PLoS Pathogens

Tetanus vaccination with a dissolving microneedle patch confers protective immune responses in pregnancy

(2016) E. Stein Esser et al.   JOURNAL OF CONTROLLED RELEASE

Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model

(2016) Matthew J. Memoli et al.   mBio

Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection

(2015) Arnold S. Monto et al.   JOURNAL OF INFECTIOUS DISEASES

Advances in the development of influenza virus vaccines

(2015) Florian Krammer et al.   NATURE REVIEWS DRUG DISCOVERY

Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice

(2015) Teddy John Wohlbold et al.   mBio

In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen

(2014) Teddy Wohlbold et al.   Viruses-Basel

Comparison of Serum Hemagglutinin and Neuraminidase Inhibition Antibodies After 2010-2011 Trivalent Inactivated Influenza Vaccination in Healthcare Personnel

(2014) M. R. Laguio-Vila et al.   Open Forum Infectious Diseases

Universal anti-neuraminidase antibody inhibiting all influenza A subtypes

(2013) Tracey M. Doyle et al.   ANTIVIRAL RESEARCH

Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies

(2013) F. Krammer et al.   JOURNAL OF VIROLOGY

Residual Baculovirus in Insect Cell-Derived Influenza Virus-Like Particle Preparations Enhances Immunogenicity

(2012) Irina Margine et al.   PLoS One

The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferrets

(2012) Zhongying Chen et al.   VACCINE

Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines

(2012) Robert B. Couch et al.   VACCINE

Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection

(2012) Fu-Shi Quan et al.   VIROLOGY

Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice

(2012) Judith D. Easterbrook et al.   VIROLOGY

A Contributing Role for Anti-Neuraminidase Antibodies on Immunity to Pandemic H1N1 2009 Influenza A Virus

(2011) Glendie Marcelin et al.   PLoS One

Trichoplusia ni cells (High FiveTM) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines

(2010) Florian Krammer et al.   MOLECULAR BIOTECHNOLOGY

Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences

(2010) Caroline Gravel et al.   VACCINE

Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle

(2008) Rick A. Bright et al.   PLoS One